Evidence map›Paper›PMID 22249261›Full record

ArticleOncogene2012

Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma.

S Fatima, N P Lee, F H Tsang, F T Kolligs, I O L Ng, R T P Poon, S T Fan, J M Luk

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Wnt antagonist as therapeutic targets in ovarian cancer.The international journal of biochemistry & cell biology · 2022
    Review
  9. Review
  10. A literature review on function and regulation mechanism of DKK4.Journal of cellular and molecular medicine · 2021
    Review
  11. Methylation Assessment of TwoIranian journal of public health · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Role of DKK4 in Tumorigenesis and Tumor Progression.International journal of biological sciences · 2018
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

S FatimaDepartment of Surgery, The University of Hong Kong, Pokfulam, Hong Kong.
N P Lee
F H Tsang
F T Kolligs
I O L Ng
R T P Poon
S T Fan
J M Luk
University of Hong Kong · HKNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deregulation of Wnt/β-catenin pathway is a hallmark of major gastrointestinal cancers including hepatocellular carcinoma (HCC). The oncogenic role of β-catenin is well defined but reasons for its accumulation in HCC remain unclear. Dickkopf 4 (DKK4) acts as a negative regulator of Wnt/β-catenin pathway but its functional role in liver carcinogenesis has not been studied. We investigated the role of DKK4 in β-catenin regulation in HCC. Reduced expression of DKK4 was found in 47% (38/81) of HCC, as measured by quantitative real time PCR. Ectopic expression of DKK4 in two HCC cell lines, PLC/PRF/5 (PLC) and MHCC97L (97L), attenuated β-catenin responsive luciferase activity, and decreased both β-catenin and cyclin D1 protein levels. To study the effect of DKK4 on cell growth and tumourigenicity, two stable HCC cell lines were established from PLC and 97L cells. Functional assays demonstrated that overexpression of DKK4 hampered cell proliferation, reduced colony formation and retarded cell migration. When DKK4-expressing 97L stable cells were used to induce tumour xenografts in nude mice (n=8), reduction in tumour sizes was observed (P=0.027). Furthermore, immunohistochemical studies showed that decreased expression of DKK4 was associated with β-catenin accumulation in HCC tissues. Additionally, inhibition of the proteasome using specific inhibitor in DKK4-expressing 97L stable cells masked the effect of β-catenin. Our findings suggest a potential tumour suppressive role of DKK4 as well as that of an important regulator of HCC.

Indexed as

Signal TransductionAnimalsbeta CateninCarcinoma, HepatocellularCell Line, TumorCell Transformation, NeoplasticGene Expression Regulation, NeoplasticGenes, ReporterGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHumansIntercellular Signaling Peptides and ProteinsLiver NeoplasmsMaleMiceMice, Inbred BALB Cbeta CateninDKK4 protein, humanGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaIntercellular Signaling Peptides and ProteinsProteasome Endopeptidase ComplexWnt Proteins

Identifiers

PMID22249261
OpenAlexW1974864882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.